Summary
The management of asthma typically involves a stepwise approach to therapy, but the availability of biologic therapies and recent advances that allow better characterization of patients now facilitate individualization of therapy, particularly for patients with moderate-to-severe asthma. Currently available therapies are highly effective for asthma management, but in practice, asthma control often remains suboptimal, particularly among patients with severe asthma. This course will address diagnosis, treatment, and clinician-patient communication strategies to optimize patient care.
This webcast was recorded live at the Conversations in Pulmonology Live Virtual Broadcast and is being used with the permission of the presenters.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Identify severe asthma phenotypes and modifiable and non-modifiable factors that contribute to difficult-to-treat or severe asthma, in order to make personalized treatment decisions
- Implement the most effective current guideline-directed therapy, based on the individualized characteristics of patients with difficult-to-treat or severe asthma
- Utilize shared decision-making, including the use of clear and concise asthma-education strategies, to enhance patient empowerment and engagement, improve symptom control, and reduce hospitalizations and emergency room visits
Speaker
Njira Lugogo, MD, MS
Associate Professor of Internal Medicine
Division of Pulmonary & Critical Care Medicine
Asthma Program Director
University of Michigan
Ann Arbor, MI
Stanford, CA
Course Director and Moderator
Fernando J. Martinez, MD, MS
Chief, Division of Pulmonary and Critical Care Medicine
Bruce Webster Professor of Medicine
Joan and Sanford I. Weill Department of Medicine
Weill Cornell Medical College
New York-Presbyterian Hospital/Weill Cornell Medical Center
New York, NY